Kiromic BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 87.5%.

Top 16 shareholders own 36.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.4%	Empery Asset Management, LP	179,653	€508.4k	996%	2.1%
6.21%	Sabby Management, LLC	60,762	€171.9k	0%	0.56%
5.76%	Yorkville Advisors Global LP	56,366	€159.5k	180%	0.65%
2.19%	Pietro Bersani	21,453	€60.7k	0.83%	no data
1.68%	Susquehanna International Group, LLP, Asset Management Arm	16,457	€46.6k	0%	no data
0.64%	Americo Cicchetti	6,296	€17.8k	0%	no data
0.64%	Michael Nagel	6,296	€17.8k	0%	no data
0.36%	Zeke Capital Advisors, LLC	3,566	€10.1k	0%	no data
0.16%	Tower Research Capital LLC	1,559	€4.4k	906%	no data
0.14%	Geode Capital Management, LLC	1,365	€3.9k	0%	no data
0.12%	UBS Asset Management AG	1,222	€3.5k	-5.34%	no data
0.083%	BlackRock, Inc.	809	€2.3k	0%	no data
0.013%	Leonardo Mirandola	132	€373.5	0%	no data
0.0041%	Morgan Stanley, Investment Banking and Brokerage Investments	40	€113.1	0%	no data
0.00082%	Group One Trading LP, Asset Management Arm	8	€22.7	33.3%	no data
0.00041%	Wells Fargo & Company, Private Banking and Investment Banking Arm	4	€11.4	100%	no data